[go: up one dir, main page]

DK157685C - Analogifremgangsmaade til fremstilling af (6r,7r)-7-oe(z)-2-(2-aminotiazol)-4-yl)-2-(2-karboxyprop-2-oxyimino)-acetamidoaa-3-(1-pyridiniummetyl)-ceph-3-em-4-karboxylat eller ugiftige salte eller ugiftige metabolisk labile estere deraf - Google Patents

Analogifremgangsmaade til fremstilling af (6r,7r)-7-oe(z)-2-(2-aminotiazol)-4-yl)-2-(2-karboxyprop-2-oxyimino)-acetamidoaa-3-(1-pyridiniummetyl)-ceph-3-em-4-karboxylat eller ugiftige salte eller ugiftige metabolisk labile estere deraf

Info

Publication number
DK157685C
DK157685C DK216779A DK216779A DK157685C DK 157685 C DK157685 C DK 157685C DK 216779 A DK216779 A DK 216779A DK 216779 A DK216779 A DK 216779A DK 157685 C DK157685 C DK 157685C
Authority
DK
Denmark
Prior art keywords
toxic
acetamidoaa
aminotiazol
carboxyprop
ceph
Prior art date
Application number
DK216779A
Other languages
Danish (da)
English (en)
Other versions
DK216779A (da
DK157685B (da
Inventor
Cynthia Hilda O'callaghan
David George Hubert Livermore
Christopher Earle Newall
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DK216779A publication Critical patent/DK216779A/da
Publication of DK157685B publication Critical patent/DK157685B/da
Application granted granted Critical
Publication of DK157685C publication Critical patent/DK157685C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
DK216779A 1978-05-26 1979-05-25 Analogifremgangsmaade til fremstilling af (6r,7r)-7-oe(z)-2-(2-aminotiazol)-4-yl)-2-(2-karboxyprop-2-oxyimino)-acetamidoaa-3-(1-pyridiniummetyl)-ceph-3-em-4-karboxylat eller ugiftige salte eller ugiftige metabolisk labile estere deraf DK157685C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB2291178 1978-05-26
GB2291378 1978-05-26
GB2291378 1978-05-26
GB2291178 1978-05-26

Publications (3)

Publication Number Publication Date
DK216779A DK216779A (da) 1979-11-27
DK157685B DK157685B (da) 1990-02-05
DK157685C true DK157685C (da) 1990-07-09

Family

ID=26256190

Family Applications (1)

Application Number Title Priority Date Filing Date
DK216779A DK157685C (da) 1978-05-26 1979-05-25 Analogifremgangsmaade til fremstilling af (6r,7r)-7-oe(z)-2-(2-aminotiazol)-4-yl)-2-(2-karboxyprop-2-oxyimino)-acetamidoaa-3-(1-pyridiniummetyl)-ceph-3-em-4-karboxylat eller ugiftige salte eller ugiftige metabolisk labile estere deraf

Country Status (27)

Country Link
US (2) US4258041A (fi)
AR (2) AR229883A1 (fi)
AT (1) AT370420B (fi)
AU (1) AU524671B2 (fi)
CA (1) CA1127633A (fi)
CH (2) CH649556A5 (fi)
DE (1) DE2921316C2 (fi)
DK (1) DK157685C (fi)
ES (2) ES480915A1 (fi)
FI (2) FI67555C (fi)
FR (2) FR2426695A1 (fi)
HK (1) HK40183A (fi)
IE (2) IE49173B1 (fi)
IL (3) IL59793A (fi)
IT (1) IT1116198B (fi)
KE (1) KE3252A (fi)
LU (1) LU81319A1 (fi)
MY (1) MY8400017A (fi)
NL (2) NL176855C (fi)
NO (2) NO155347C (fi)
NZ (2) NZ190558A (fi)
PH (1) PH16961A (fi)
PT (2) PT69669A (fi)
SE (2) SE438507B (fi)
SG (1) SG58382G (fi)
SI (2) SI7911231A8 (fi)
YU (2) YU41635B (fi)

Families Citing this family (112)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963542A (en) * 1976-09-08 1990-10-16 Takeda Chemical Industries, Ltd. Cephalosporin derivatives
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
AR229883A1 (es) * 1978-05-26 1983-12-30 Glaxo Group Ltd Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato
US4237128A (en) * 1979-04-12 1980-12-02 E. R. Squibb & Sons, Inc. 7-[2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1,1-dialkyl)alkoxyimino]acetamido]cephem sulfoxides
CH654010A5 (de) * 1979-05-25 1986-01-31 Glaxo Group Ltd Zwischenprodukte zur verwendung bei der herstellung von cephalosporin-antibiotika.
US4329453A (en) * 1979-10-02 1982-05-11 Glaxo Group Limited Cephalosporin antibiotic
ZA806084B (en) * 1979-10-02 1982-05-26 Glaxo Group Ltd Cephalosporin antibiotics
NL8005439A (nl) * 1979-10-02 1981-04-06 Glaxo Group Ltd Verbeteringen aan of met betrekking tot een cefalosporine met antibiotische werking.
US4338313A (en) * 1979-10-12 1982-07-06 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4332800A (en) * 1979-10-12 1982-06-01 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
DE3006888A1 (de) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
FR2476647A2 (fr) * 1980-02-26 1981-08-28 Roussel Uclaf Procede de preparation de derives de l'acide 2-(2-amino protege 4-thiazolyl) 2-alkoxyimino acetique isomere syn
US4252802A (en) * 1980-03-13 1981-02-24 E. R. Squibb & Sons, Inc. Hydroxamic acid derivatives of 7-[(2-amino-4-thiazolyl)-oximino] cephalosporins
GR75706B (fi) * 1980-06-30 1984-08-02 Sanofi Sa
US4443444A (en) * 1980-08-11 1984-04-17 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
EP0156118A1 (en) * 1980-08-29 1985-10-02 Fujisawa Pharmaceutical Co., Ltd. New starting compounds for the preparation of cephem compounds and processes for preparation thereof
NZ198350A (en) * 1980-09-25 1985-02-28 Toyama Chemical Co Ltd Cephalosporins and intermediates;pharmaceutical compositions
FR2494276A2 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouvelles vinyl-3 cephalosporines, et leur preparation
US4427677A (en) 1980-12-31 1984-01-24 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
JPS57144291A (en) * 1981-03-02 1982-09-06 Ajinomoto Co Inc Preparation of imidazoledicarboxylic acid derivative
US4336253A (en) * 1981-03-11 1982-06-22 Eli Lilly And Company Cephalosporin antibiotics
JPS6011917B2 (ja) * 1981-04-09 1985-03-28 山之内製薬株式会社 新規なセファロスポリン化合物
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
GR75487B (fi) * 1981-06-22 1984-07-23 Fujisawa Pharmaceutical Co
US4430499A (en) 1981-09-08 1984-02-07 Eli Lilly And Company 7-[2-(2-Aminooxazol-4-yl)-2-(oximino)acetamido]cephalosporin antibiotics
US4382931A (en) * 1981-09-08 1983-05-10 Eli Lilly And Company 3'-Substituted quinolinium cephalosporins
US4406898A (en) * 1981-09-08 1983-09-27 Eli Lilly And Company Oxazole and oxadiazole cephalosporins
US4436912A (en) 1981-09-08 1984-03-13 Eli Lilly And Company 7-[2-(2-Aminooxazol-4-yl)-2-(oximino)acetamido cephalosporin antibiotics and intermediates therefor
US4382932A (en) * 1981-09-08 1983-05-10 Eli Lilly And Company Isoquinolinium substituted cephalosporins
US4577014A (en) * 1981-09-08 1986-03-18 Eli Lilly And Company Thieno and furopyridinium-substituted cephalosporins
JPS5859991A (ja) * 1981-09-14 1983-04-09 Fujisawa Pharmaceut Co Ltd 新規セフェム化合物
US4450270A (en) * 1981-10-02 1984-05-22 Eli Lilly And Company Dioximino cephalosporin antibiotics
US4379787A (en) * 1981-10-02 1983-04-12 Eli Lilly And Company Oximino-substituted cephalosporin compounds
US4402955A (en) * 1981-10-02 1983-09-06 Eli Lilly And Company Dioximino cephalosporin antibiotics
US4401668A (en) * 1981-10-02 1983-08-30 Eli Lilly And Company Pyrazinium substituted cephalosporins
US4388316A (en) * 1981-10-02 1983-06-14 Eli Lilly And Company Amino-substituted oxazole, oxadiazole and isoxazole-substituted cephalosporins
US4406887A (en) * 1981-10-13 1983-09-27 Bristol-Myers Company Method for treating resistant bacteria including anaerobes
US4493933A (en) * 1981-11-13 1985-01-15 Glaxo Group Limited Manufacture of antibiotics
EP0088847B1 (en) * 1981-11-13 1986-02-26 Glaxo Group Limited Thiazole derivatives and their use in the manufacture of beta-lactam antibiotics
US4474954A (en) * 1981-12-07 1984-10-02 Bristol-Myers Company Intermediates for cephalosporin derivatives
US4394503A (en) * 1981-12-07 1983-07-19 Bristol-Myers Company Cephalosporin derivatives
US4501739A (en) * 1982-01-19 1985-02-26 Eli Lilly And Company Thieno and furopyridinium-substituted cephalosporins
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
DE3207840A1 (de) * 1982-03-04 1983-09-15 Hoechst Ag, 6230 Frankfurt "cephalosporinderivate und verfahren zu ihrer herstellung"
US4552696A (en) * 1982-04-09 1985-11-12 Bristol-Myers Company Carbapenem antibiotics
ATE31532T1 (de) * 1982-04-29 1988-01-15 Glaxo Group Ltd Thiazolderivat, verfahren zu seiner herstellung sowie seine verwendung bei der herstellung von beta-lactam-antibiotika.
DE3374410D1 (en) 1982-06-28 1987-12-17 Bristol Myers Co Cephalosporin derivatives, a process for the manufacture thereof and pharmaceutical compositions containing said derivatives
IE55406B1 (en) * 1982-08-07 1990-09-12 Tanabe Seiyaku Co Novel cephalosporin compounds and preparation thereof
ES525492A0 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
EP0113568B1 (en) * 1982-12-27 1990-04-04 Eli Lilly And Company Intermediates for the preparation of ceftazidine, and process for their preparation
EP0115770B2 (en) * 1983-01-07 1996-06-19 Takeda Chemical Industries, Ltd. Thiazole Derivatives
US4486586A (en) * 1983-02-10 1984-12-04 Bristol-Myers Company Cephalosporin derivatives
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3313816A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3316797A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
DE3316798A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
US4540779A (en) * 1983-06-20 1985-09-10 Eli Lilly And Company Crystalline 7-(R)-amino-3-(1'pyridiniummethyl)-ceph-3-em-4-carboxylate monohydrochloride monohydrate compound
US4497811A (en) * 1983-07-01 1985-02-05 Seiji Shibahara 1-Oxadethiacephalosporin compound and antibacterial agent containing the _same
JPS6061528A (ja) * 1983-09-09 1985-04-09 ブリストル―マイヤーズ　スクイブ　カンパニー 嫌気性菌を包含する耐性バクテリアの処理法
AU566944B2 (en) * 1983-10-07 1987-11-05 Gist-Brocades N.V. Preparation of 3-cephem derivatives
JPS60178891A (ja) * 1984-02-24 1985-09-12 Kureha Chem Ind Co Ltd セファロスポリン誘導体及び該誘導体を含有する医薬
GB8406218D0 (en) * 1984-03-09 1984-04-11 Glaxo Group Ltd Process
US4537959A (en) * 1984-03-26 1985-08-27 Eli Lilly And Company Crystalline cephalosporin antibiotic salt
US4788185A (en) * 1984-04-23 1988-11-29 Takeda Chemical Industries, Ltd. Cephalosporin compounds
PH22107A (en) * 1984-06-07 1988-06-01 Takeda Chemical Industries Ltd 3-pyrazolo(1,5-a)pyrdinium cephem compounds
CA1236089A (en) * 1984-06-25 1988-05-03 Perry C. Heath Ceftazidime
US4616080A (en) * 1984-07-02 1986-10-07 Eli Lilly And Company Simplified process of forming crystalline ceftazidime pentahydrate
US4626534A (en) * 1984-07-23 1986-12-02 Eli Lilly And Company Pharmaceutical formulation
IL76367A0 (en) * 1984-09-17 1986-01-31 Lilly Co Eli Improved process for cephalsporin intermediates
US4659813A (en) * 1984-11-08 1987-04-21 Eli Lilly And Company Crystallization process for ceftazidime derivative
GB8504072D0 (en) * 1985-02-18 1985-03-20 Fujisawa Pharmaceutical Co Cephem compounds
ATE89826T1 (de) * 1985-03-01 1993-06-15 Takeda Chemical Industries Ltd Antibakterielle verbindungen, ihre herstellung und verwendung.
US4703118A (en) * 1985-04-08 1987-10-27 Eli Lilly And Company Synthesis of 3-iodomethyl cephalosporins
US4692518A (en) * 1985-11-06 1987-09-08 Eli Lilly And Company Crystalline (7R)-7-amino-3-(1'-pyridiniummethyl)-3-cephem-4-carboxylate monohydrate compound
JPS62175489A (ja) * 1986-01-29 1987-08-01 Sanwa Kagaku Kenkyusho:Kk 新規なセフアロスポリン誘導体及びその塩、これらの製法並びに該化合物を有効成分とする感染症治療剤
US5359057A (en) * 1986-02-07 1994-10-25 Hoffmann-La Roche Inc. Acylation of amines
JPS63107989A (ja) * 1986-06-04 1988-05-12 Tanabe Seiyaku Co Ltd セファロスポリン化合物
AT387022B (de) * 1986-06-04 1988-11-25 Biochemie Gmbh Verfahren zur herstellung einer neuen kristallinen form eines cefalosporinderivats
IL82738A0 (en) * 1986-06-16 1987-12-20 Tanabe Seiyaku Co Cephalosporin compounds,their preparation and pharmaceutical compositions containing them
WO1988002001A1 (en) * 1986-09-10 1988-03-24 Biochemie Gesellschaft M.B.H. New stable crystalline form of an intermediate product of cephalosporine
US4954624A (en) * 1986-10-07 1990-09-04 Sandoz Ltd. Process for the production of cephalosporin derivatives
EP0278656B1 (en) * 1987-02-02 1992-06-03 Eli Lilly And Company Process for preparing ceftazidime pentahydrate
US5021564A (en) * 1987-02-02 1991-06-04 Eli Lilly And Company Process for preparing ceftazidime pentahydrate
EP0321562B1 (en) * 1987-06-25 1993-11-24 Banyu Pharmaceutical Co., Ltd. Crystalline cephalosporin compounds, process for their preparation, and intermediates for their preparation
GB8802622D0 (en) * 1988-02-05 1988-03-02 Glaxo Group Ltd Chemical compound
EP0377987A3 (en) * 1988-12-27 1991-08-28 Eli Lilly And Company Acylation process for obtaining cephalosporin derivatives
US5194604A (en) * 1990-06-29 1993-03-16 E. R. Squibb & Sons, Inc. Process and intermediates for beta-lactams having aminothiazole(iminooxyacetic acid)acetic acid sidechains
KR940000112B1 (ko) * 1990-07-05 1994-01-05 주식회사 대웅제약 신규의 3-치환 세펨화합물 및 그의 제조방법
US5281589A (en) * 1991-06-15 1994-01-25 Cheil Foods & Chemicals, Inc. 3-fused pyridiniummethyl cephalosporins
KR100194994B1 (ko) * 1993-06-05 1999-06-15 손경식 새로운 세펨 화합물
US6472383B1 (en) 1994-04-25 2002-10-29 Smithkline Beecham P.L.C. Pharmaceutical formulations
KR100363604B1 (ko) * 1994-04-25 2003-04-11 스미스크라인 비참 피.엘.시. 베타-락탐항생물질과함께베타-락타마제억제페넴을함유하는약제제형및이것의세균감염의치료에서의용도
CA2190245A1 (en) * 1994-05-23 1995-11-30 Joong Hyup Kim Cephalosporin compounds and processes for the preparation thereof
US5831085A (en) * 1997-01-16 1998-11-03 Lupin Laboratories Limited Process for manufacture of cephalosporin such as ceftazidime and intermediate thereof
IN189047B (fi) 1998-06-01 2002-12-14 Ranbaxy Lab Ltd
US6930983B2 (en) * 2000-03-15 2005-08-16 Texas Instruments Incorporated Integrated circuits, systems, apparatus, packets and processes utilizing path diversity for media over packet applications
KR100342600B1 (ko) 2000-03-06 2002-07-04 한미정밀화학주식회사 신규한 티아졸 화합물 및 그의 제조 방법
KR100392409B1 (ko) 2000-03-20 2003-07-22 한미정밀화학주식회사 신규한 티아졸 화합물을 이용한 세팔로스포린계항생물질의 제조 방법
US6911441B2 (en) * 2002-12-16 2005-06-28 Akzo Nobel N.V. Prolonged release pharmaceutical composition
CN1312158C (zh) * 2005-05-20 2007-04-25 天津市医药集团技术发展有限公司 一种头孢克肟的制备方法
WO2009049086A1 (en) 2007-10-09 2009-04-16 Larry Sutton Broad spectrum beta-lactamase inhibitors
CN101293891B (zh) * 2008-06-12 2011-01-12 齐鲁安替制药有限公司 头孢他啶中间体的制备方法
RS66326B1 (sr) 2011-09-09 2025-01-31 Merck Sharp & Dohme Llc Ceftolozan/tazobaktam za lečenje intrapulmonalnih infekcija
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
MD4599C1 (ro) 2013-03-13 2019-06-30 Theravance Biopharma Antibiotics Ip, Llc Săruri de hidroclorură a unui compus antibiotic
NZ700372A (en) 2013-03-15 2016-01-29 Merck Sharp & Dohme Ceftolozane antibiotic compositions
US20140274990A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN106336418B (zh) * 2016-08-19 2019-02-01 上海上药新亚药业有限公司 一种头孢他啶盐酸盐的固相合成法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017515A (en) * 1971-05-14 1977-04-12 Glaxo Laboratories Limited α-(Etherified oximino) carboxylic acids and acid chlorides
GB1399086A (en) 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
US4064346A (en) * 1971-05-14 1977-12-20 Glaxo Laboratories Limited 3-Acetoxymethyl-7β-(2-carboxy-methoxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof
US4079178A (en) * 1971-05-14 1978-03-14 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino) acylamido groups at the 7-position
US4092477A (en) * 1971-05-14 1978-05-30 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins
US3971778A (en) * 1972-05-12 1976-07-27 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino)acylamido groups at the 7-position
US4093803A (en) * 1971-05-14 1978-06-06 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(thienyl-, furyl- or pyridylacetamido)] cephalosporins
US4024137A (en) * 1971-05-14 1977-05-17 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins
US4033950A (en) * 1971-05-14 1977-07-05 Glaxo Laboratories Limited 3-Hydroxymethyl-7β-(2-alkoxy-or benzyloxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof
US4024133A (en) * 1971-05-14 1977-05-17 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(thienyl-,furyl- or pyridylacetamido)]cephalosporins
US4060686A (en) * 1973-12-21 1977-11-29 Janice Bradshaw Cephalosporins having a 7-(carboxy substituted α-etherified oximinoarylacetamido) group
US4162360A (en) * 1973-12-21 1979-07-24 Glaxo Laboratories Limited 3-Carbamoyloxymethyl-7-substituted oximino acetamido cephalosporanic acid derivatives
US4144392A (en) * 1973-12-21 1979-03-13 Glaxo Laboratories Limited Cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyimino-arylacetamido group and at position-3 the residue of a sulphur nucleophile
US4144393A (en) * 1973-12-21 1979-03-13 Glaxo Laboratories Limited 3-Acetoxymethyl cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyiminoarylacetamido group
GB1496757A (en) 1973-12-21 1978-01-05 Glaxo Lab Ltd Cephalosporin derivatives
US4032950A (en) * 1974-12-06 1977-06-28 Hughes Aircraft Company Liquid phase epitaxial process for growing semi-insulating gaas layers
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
US4165430A (en) * 1976-03-19 1979-08-21 Glaxo Laboratories Limited Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group
US4166115A (en) * 1976-04-12 1979-08-28 Fujisawa Pharmaceutical Co., Ltd. Syn 7-oxoimino substituted derivatives of cephalosporanic acid
JPS52125188A (en) 1976-04-14 1977-10-20 Takeda Chem Ind Ltd Cephalosporin derivatives and their preparation
AU520269B2 (en) 1977-03-14 1982-01-21 Fujisawa Pharmaceutical Co., Ltd. Cephem and cepham compounds
FR2384782A1 (fr) 1977-03-25 1978-10-20 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-acetoxymethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
ZA781870B (en) 1977-04-02 1979-03-28 Hoechst Ag Cephem derivatives and process for their manufacture
DE2716677C2 (de) 1977-04-15 1985-10-10 Hoechst Ag, 6230 Frankfurt Cephemderivate und Verfahren zu ihrer Herstellung
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
GB1602725A (en) 1977-04-27 1981-11-18 Glaxo Operations Ltd 7-(a-oxyiminoacetamido)-ceph-3-em-4-carboxylic acid derivatives
AR229883A1 (es) * 1978-05-26 1983-12-30 Glaxo Group Ltd Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato
US4237128A (en) * 1979-04-12 1980-12-02 E. R. Squibb & Sons, Inc. 7-[2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1,1-dialkyl)alkoxyimino]acetamido]cephem sulfoxides
US4394503A (en) * 1981-12-07 1983-07-19 Bristol-Myers Company Cephalosporin derivatives

Also Published As

Publication number Publication date
CH646178A5 (de) 1984-11-15
FR2445835A1 (fr) 1980-08-01
IL59793A0 (en) 1980-06-30
AR228726A1 (es) 1983-04-15
FI801609A (fi) 1980-05-19
NZ190558A (en) 1982-05-31
AT370420B (de) 1983-03-25
NO155347B (no) 1966-12-08
PT69669A (en) 1979-06-01
NL176855B (nl) 1985-01-16
HK40183A (en) 1983-10-21
NL8001348A (nl) 1980-06-30
ES480915A1 (es) 1980-02-01
AU4742279A (en) 1979-11-29
ES480914A1 (es) 1980-02-01
IT1116198B (it) 1986-02-10
SE8402887L (sv) 1984-05-28
AU524671B2 (en) 1982-09-30
CA1127633A (en) 1982-07-13
YU223482A (en) 1983-04-30
NO155347C (no) 1987-03-18
NO791731L (no) 1979-11-27
FR2426695A1 (fr) 1979-12-21
PH16961A (en) 1984-04-27
YU41635B (en) 1987-12-31
IE49173B1 (en) 1985-08-21
FI67705C (fi) 1985-05-10
SE8402887D0 (sv) 1984-05-28
US4600772A (en) 1986-07-15
FI67705B (fi) 1985-01-31
SG58382G (en) 1983-09-02
IE49172B1 (en) 1985-08-21
DK216779A (da) 1979-11-27
DK157685B (da) 1990-02-05
DE2921316A1 (de) 1979-12-06
AR229883A1 (es) 1983-12-30
SI8212234A8 (en) 1997-06-30
ATA239281A (de) 1982-08-15
IE791025L (en) 1979-11-26
DE2921316C2 (de) 1982-09-16
FR2426695B1 (fi) 1982-06-11
FI791678A (fi) 1979-11-27
YU43097B (en) 1989-02-28
SE7904576L (sv) 1980-02-11
FI67555B (fi) 1984-12-31
IL57400A (en) 1982-08-31
NL176855C (nl) 1985-06-17
SI7911231A8 (en) 1997-06-30
LU81319A1 (fr) 1979-09-11
FI67555C (fi) 1985-04-10
NL7904122A (nl) 1979-11-28
US4258041A (en) 1981-03-24
IE802453L (en) 1979-11-26
KE3252A (en) 1983-01-28
CH649556A5 (de) 1985-05-31
YU123179A (en) 1983-01-21
MY8400017A (en) 1984-12-31
NO850153L (no) 1979-11-27
NZ193326A (en) 1982-05-31
SE438507B (sv) 1985-04-22
IL57400A0 (en) 1979-09-30
IL59793A (en) 1982-08-31
FR2445835B1 (fi) 1983-06-03
PT69670A (en) 1979-06-01

Similar Documents

Publication Publication Date Title
DK157685C (da) Analogifremgangsmaade til fremstilling af (6r,7r)-7-oe(z)-2-(2-aminotiazol)-4-yl)-2-(2-karboxyprop-2-oxyimino)-acetamidoaa-3-(1-pyridiniummetyl)-ceph-3-em-4-karboxylat eller ugiftige salte eller ugiftige metabolisk labile estere deraf
DK155525C (da) Fremgangsmaade til fremstilling af (6r,7r)-7-oe(z)-2-(2-aminotiazol-4-yl)-2-(2-karboxyprop-2-oxyimino)-acetamidoaa-3-(1-pyridiniummetyl)-ceph-3-em-4-karboxylat-pentahydrat
DK481879A (da) Fremgangsmaade til fremstilling af 5-(2-imidazolin-2-yl)-aminopyrimidiner eller syreadditionssalte deraf
DK158788C (da) Analogifremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater
DK152495C (da) Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk tolerable salte deraf
DK28282A (da) Fremgangsmaade til fremstilling af hexapyranoseforbindelser eller salte deraf
NL7604730A (nl) Werkwijze voor het bereiden van wateropnemende celluloseethers.
DK120780A (da) Fremgangsmaade til fremstilling af phenyl- eller phenoxy-substituerede spiro-imidazolidindionderivater eller salte deraf
DK147683C (da) Analogifremgangsmaade til fremstilling af cephalosporinforbindelser eller ugiftige salte, biologisk acceptable estere, 1-oxyder eller solvater deraf
DK536480A (da) Fremgangsmaade til fremtlling af isoquinolineddikesyre-forbindelser eller salte deraf
DK146386C (da) Analogifremgangsmaade til fremstilling af phenylalkanolamin-forbindelser eller salte deraf
DK157027C (da) Fremgangsmaade til fremstilling af 7beta-amino-3-cephem-3-o1-4-carboxylsyreforbindelser eller salte deraf
DK284779A (da) Fremgangsmaade til fremstilling af 7-amino-3-(substitueret) thiomethyl-delta3-cephem-4-carxoxylsyre-forbindelser eller derivater i carboxylgruppen deraf eller salte deraf
NL7604682A (nl) Werkwijze voor het bereiden van wateropnemende celluloseethers.
DK152042C (da) Analogifremgangsmaader til fremstilling af n-cycloalkylmethyl-2-phenyl-aminoimidazolin-forbindelser eller syreadditionssalte deraf
DK113286B (da) Fremgangsmåde til fremstilling af phenoxy- eller phenylmercaptoderivater af monocarboxylsyrer eller salte heraf.
DK144301C (da) Analogifremgangsmaade til fremstilling af penicilliner eller salte deraf
NL7713649A (nl) Werkwijze voor het bereiden van benzothiazool- verbindingen.
DK365980A (da) Fremgangsmaade til fremstilling af 7-betaaminothiadiazolylacetylamino-3-cephem-4-carboxylsyreforbindelser eller salte deraf
DK223177A (da) Fremgangsmade til fremstilling af p-acylaminobenzamid-forbindelser eller salte deraf
DK144569C (da) Fremgangsmaade til fremstilling af et antibiotisk anthracyclin-glycosid-kompleks kaldet baumycin-kompleks eller komponenter,syreadditionssalte eller deoxyribonukleinsyrekomplekser deraf
DK119883B (da) Fremgangsmåde til fremstilling af basiske ætere eller disse forbindelsers syreadditionssalte eller kvartære forbindelser.
DK144098C (da) Fremgangsmaade til fremstilling af antibiotikum ps-5 eller salte eller estere deraf
DK452579A (da) Fremgangsmaade til fremstilling af cephalosporinforbindelser eller salte eller metalbolisk labile estere deraf
NL7711453A (nl) Werkwijze voor het biologisch voorbehandelen van lignocellulose ter verwijdering van lignien.